DOD Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award (OCCTAECIA) LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Monday 17th, June 2024
External Deadline: Monday 24th, June 2024
Description
The Department of Defense (DOD) Ovarian Cancer Research Program (OCRP) was initiated in FY97 to support high-impact, cutting-edge research that fills unmet needs. The OCRP establishes priorities to target the most critical needs along the research development pipeline from basic to translational to clinical research, including clinical trials, and to push the field of ovarian cancer forward to our vision to “eliminate ovarian cancer.”
In FY23, the OCRP established a new academy, the Ovarian Cancer Clinical Trial Academy
(OCCTA), which will focus on clinical trial research in ovarian cancer. The intent of the
OCCTA is to enhance knowledge within next generation of Early-Career Investigators (ECIs) in
clinical trial research and to produce effective treatments and cures for ovarian cancer. The
OCCTA will bring together established investigators (the Academy Dean and Assistant Dean),
established Career Guides (mentors), and a group of ECIs/Scholars to conduct successful, highly
productive clinical trials in ovarian cancer. The OCCTA strives to develop successful, highly
productive ovarian cancer clinical trialists in a collaborative research and career development
environment, providing intensive mentoring, national networking, collaborations, and a peer
group for junior clinical trialists. The OCCTA, through its Leadership, provides for professional
and leadership development of the ECIs to include skills and competencies needed to execute
clinical trials.
This FY24 program announcement is soliciting the first group of ECIs to join the new OCCTA.
This Ovarian Cancer Clinical Trial Academy – Early-Career Investigator (OCCTA – ECI)
Award mechanism enables the ECI (the investigator named as the Principal Investigator [PI] on
the application) to pursue funding for ovarian cancer clinical trial research under the guidance of
a Designated Mentor. Because of the early career nature of the PI, clinical trials initiated or
collaborated with during the award period of performance are anticipated to be the led by the
Designated Mentors. Beyond research, OCCTA ECIs will be expected to participate in monthly
webinars and annual workshops and to communicate and collaborate with other members of the
OCCTA (other ECIs, Mentors, Dean, Assistant Dean) as well as with the advocacy community.
Research funded under this FY24 program announcement will support translational research
and small-scale, early-phase clinical trials in ovarian cancer. Examples of clinical trial focuses
that are encouraged include but are not limited to diagnostic or prevention-focused studies,
DOD FY24 Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award 4
dietary or lifestyle interventions, therapeutic or surgical interventions, studies on quality of life,
and repurposed drug trials. Preliminary data to support the feasibility of the research
hypotheses and research approaches are required; however, these data do not necessarily need
to be derived from the ovarian cancer research field.
To view the funding opportunity announcement and submit a pre-application visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=581101
Pre-Application (Letter of Intent): June 24, 2024 5:00 p.m. Eastern Time
Application: August 6, 2024 11:59 p.m. Eastern Time